Skip to search formSkip to main contentSkip to account menu

paliperidone

Known as: 9-Hydroxy-risperidone, 9 Hydroxyrisperidone, 3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one 
National Institutes of Health

Related topics

Related topics

11 relations
0.5 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega]1 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega]1.5 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega]1.75 ML paliperidone palmitate 312 MG/ML Prefilled Syringe [Invega]

Narrower (2)

Invegapaliperidone palmitate

Broader (1)

Risperidone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Long-acting injectable vs oral risperidone for schizophrenia and co-occurring alcohol use disorder: a randomized trial.
OBJECTIVE Alcohol use disorders worsen the course of schizophrenia. Although the atypical antipsychotic clozapine appears to… 
Highly Cited
2009
Highly Cited
2009
Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia.
OBJECTIVE The authors compared paliperidone extended-release and quetiapine in patients with recently exacerbated schizophrenia… 
Highly Cited
2008
Highly Cited
2008
Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics.
Highly Cited
2007
Highly Cited
2007
Risperidone and Paliperidone Inhibit P-Glycoprotein Activity In Vitro
Risperidone (RSP) and its major active metabolite, 9-hydroxy-risperidone (paliperidone, PALI), are substrates of the drug… 
Highly Cited
2005
Highly Cited
2005
Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: In vivo evidence of involvement of P‐glycoprotein in risperidone disposition
2005
2005
Dose-Dependent Interaction of Paroxetine With Risperidone in Schizophrenic Patients
Abstract: Augmentation with paroxetine (10-40 mg/d) for antipsychotic treatment may improve the negative symptoms in… 
Highly Cited
2003
Highly Cited
2003
Effects of Various CYP2D6 Genotypes on the Steady-State Plasma Concentrations of Risperidone and Its Active Metabolite, 9-Hydroxyrisperidone, in Japanese Patients With Schizophrenia
The effects of various CYP2D6 genotypes on the steady-state plasma concentrations (Css) of risperidone and its active metabolite… 
Highly Cited
2001
Highly Cited
2001
Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone During Combined Treatment With Paroxetine
The effects of paroxetine on steady-state plasma concentrations of risperidone and its active metabolite 9-hydroxyrisperidone (9… 
Highly Cited
2000
Highly Cited
2000
Simultaneous determination of risperidone and 9-hydroxyrisperidone in plasma by liquid chromatography/electrospray tandem mass spectrometry.
A simple and highly sensitive liquid chromatographic/electrospray tandem mass spectrometric (LC/MS/MS) assay was developed for… 
Highly Cited
1997
Highly Cited
1997
Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in serum from patients comedicated with other psychotropic drugs.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)